This is a summary of the European public assessment report (EPAR) for Levitra. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Levitra.
Therapeutic Indication
### Therapeutic indication Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order for Levitra to be effective, sexual stimulation is required. Levitra is not indicated for use by women.
Therapeutic Area (MeSH)
N/AATC Code
G04BE09
ATC Item
vardenafil
Pharmacotherapeutic Group
Urologicals
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| vardenafil | N/A | 伐地那非 |
EMA Name
Levitra
Medicine Name
Levitra
Aliases
N/ANo risk management plan link.
